Long Acting GLP-2 (Entera Bio)

N/A

Report date: 2025/05/22 11:37:47

Base Information

Drug NameLong Acting GLP-2 (Entera Bio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 2 receptor modulators
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsShort Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEntera Bio LtdOpko Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesEntera Bio Ltd
Inactive CompaniesN/A
Active IndicationsShort Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A